Abstract:Importance Sulfamethoxazole (SMX) and cotrimoxazole (CTX), a fixed-dose combination of SMX and trimethoprim in a 5:1 ratio, are antibacterial sulfonamides commonly used for treating various diseases. A substantial prevalence of severe cutaneous adverse reactions (SCARs) following the administration of these drugs has been reported. However, the association between human leukocyte antigen (HLA) genotypes and SMX/CTX-induced SCARs has remained unclear. Objective To investigate the association between HLA genotypes and SMX/CTX-induced SCARs. Data sources A comprehensive search was conducted in CENTRAL (Cochrane Library), MEDLINE, and Embase from inception to January 17, 2023. Study Selection Case-control studies that recruited patients who had experienced SCARs following SMX or CTX were included, and HLA alleles were analyzed. Data Extraction and Synthesis Two independent authors extracted data on study characteristics and outcome data. The Meta-analysis of Observational Studies in Epidemiology ( MOOSE ) reporting guideline and the Preferred Reporting Items for Systematic Reviews and Meta-analyses ( PRISMA ) reporting guidelines were followed. The Newcastle-Ottawa Scale for case-control studies was used to assess study quality. Odds ratios (ORs) were calculated using a random-effects model for meta-analysis. Main Outcomes and Measures The prespecified outcome was the OR comparing SMX/CTX-induced SCARs with healthy or SMX/CTX-tolerant controls based on different HLA alleles. Results Six studies involving 322 patients with SCAR were included, including 236 patients with Stevens-Johnson syndrome/toxic epidermal necrolysis, 86 with drug reaction with eosinophilia and systemic symptoms, 8448 healthy controls, and 229 tolerant controls. Significant associations were found in HLA-A*11:01 (OR, 2.10; 95% CI, 1.11-4.00), HLA-B*13:01 (OR, 5.96; 95% CI, 1.58-22.56), HLA-B*15:02 (OR, 2.23; 95% CI, 1.20-4.14), HLA-B*38:02 (OR, 3.47; 95% CI, 1.42-8.48), and HLA-C*08:01 (OR, 2.63; 95% CI, 1.07-6.44) compared with tolerant controls. In the Stevens-Johnson syndrome/toxic epidermal necrolysis subgroup, significant associations were found in HLA-B*15:02 (OR, 3.01; 95% CI, 1.56-5.80) and HLA-B*38:02 (OR, 5.13; 95% CI, 1.96-13.47). In the drug reaction with eosinophilia and systemic symptoms subgroup, significant associations were found in HLA-A*68:01 (OR, 12.86; 95% CI, 1.09-151.34), HLA-B*13:01 (OR, 23.09; 95% CI, 3.31-161.00), HLA-B*39:01 (OR, 4.56; 95% CI, 1.31-15.82). Conclusions and Relevance The results of this systematic review and meta-analysis suggest that multiple HLA alleles ( HLA-A*11:01 , HLA-B*13:01, HLA-B*15:02, HLA-B*38:02, and HLA-C*0801 ) are associated with SMX/CTX-induced SCARs.

Carbamazepine-modified HLA-A*24:02-bound peptidome: Implication of CORO1A in skin rash

Structural Modeling of HLA-B*1502/peptide/carbamazepine/T-cell Receptor Complex Architecture: Implication for the Molecular Mechanism of Carbamazepine-Induced Stevens-Johnson Syndrome/toxic Epidermal Necrolysis

HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema

A study of HLA-B*15:02 in 9 different Chinese ethnics: Implications for carbamazepine related SJS/TEN

Progress on Relation Between Human Leukocyte Antigen Gene and Oxcarbazepine Induced Cutaneous Adverse Drug Reactions

Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti‐seizure medications

Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions

Carbamazepine-induced toxic epidermal necrolysis in a patient with HLA-A*31:01 allele

[Carbamazepine induced Stevens-Johnson syndrome in Han Chinese with positive HLA-A * 3101 gene: A case report]

A carbamazepine metabolite activates NLRP3 and controls skin homing of CD8 + T-cells in SJS/TEN

Purification, Crystallization and Crystallographic Analysis of HLA-B*15:02 Complexed with an Endogenous Peptide

Study on the Relationship Between Adverse Drug Reactions of Carbamazepine and HLA-B*1502 Genetic Polymorphism and Blood Concentration

Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens–Johnson syndrome/toxic epidermal necrolysis

The Association Between HLA-A03:01 and HLA-B07:02 Alleles and Oxcarbazepine-induced Maculopapular Eruption in the Uighur Chinese Population

Identification of drug-specific public TCR driving severe cutaneous adverse reactions

Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians

Unique Motif Shared by HLA-B59:01 and HLA-B55:02 is Associated with Methazolamide-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Han Chinese

Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans

Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole–Induced Severe Cutaneous Adverse Reactions

The HLA‐DRB1 Shared Epitope is Not Associated with Antibodies Against Cyclic Citrullinated Peptide in Chinese Patients with Rheumatoid Arthritis

HLA-B*59:01: a Marker for Stevens–Johnson Syndrome/toxic Epidermal Necrolysis Caused by Methazolamide in Han Chinese